Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

X-Rays 2sodium thiosulfate 1Watchful Waiting 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Receptor Protein-Tyrosine Kinases 1Radiotherapy 1Proctectomy 1Platinum 1Observation 1Microscopy, Electron 1Magnetic Resonance Spectroscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folfox protocol 1Ferrosoferric Oxide 1Enzyme-Linked Immunosorbent Assay 1Drug Therapy 1Doxorubicin 1Dasatinib 1Cytoreduction Surgical Procedures 1Copper 1Cisplatin 1Cholecalciferol 1Cetuximab 1Capecitabine 1CYT-6091 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Rectal Neoplasms × Copper × Clear all
NCT05245786 2025-11-10

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

City of Hope Medical Center

Phase EARLY_PHASE1 Recruiting
15 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡